NEWS

NEWS

The inauguration ceremony of Biosino's medical instrument and reagent production line was successfully held

2021-11-09 10:27

On January 5, 2023, the company's chairman Wu Lebin and president Chen Peng led a team, the company's shareholder representatives and the China Biosino sales team to visit and exchange at the Hefei Comprehensive National Science Center Big Health Research Institute.
On behalf of the Big Health Research Institute, Jin Tengchuan, Yangtze River Scholar and Assistant Dean of the Big Health Research Institute, extended a warm welcome to the CNBM Beijing Enterprises delegation. Professor Jin introduced the background of the establishment of the Big Health Research Institute; Teacher Zhu Chunmei, the person in charge of achievement transformation, introduced the Big Health Research Institute. Basic overview and current progress of project implementation.
Chairman Wu Lebin emphasized the importance and necessity of the construction of the Biotech Achievements Transformation Center and put forward constructive suggestions for the development of the Big Health Research Institute. Then the company delegation visited the Zhongsheng Scientific and Technological Achievements Transformation Center under construction. President Mr. Chen Peng introduced the design layout, construction progress and future project ideas of the center.
Subsequently, the company leaders visited the GMP base of China Biomedical Hefei Company and participated in the inauguration ceremony of the instrument and reagent production line, and conducted in-depth communication and discussions.
At the beginning of the meeting, Chairman Wu Lebin started with the development and invention of bovine insulin, reviewed the glorious history of Zhongsheng, and clarified the company's future development direction. He said that looking back on the past, in the turbulent development of the company, the turbulent years when batches of Zhongsheng people worked together to overcome difficulties are inspiring; looking forward to the future, with the collective efforts of all heroes, the centralized procurement won the bid and the credit leading action achieved success. The good prospects outlined by the good rating reports are inspiring.
Chairman Wu Lebin’s speech resonated strongly with President Chen Peng. Mr. Chen pointed out that in future development, Zhongsheng must adhere to "one body and two wings": with Zhongsheng's scientific and technological achievements transformation center as the main body, and application scenarios such as the research and development, incubation and transformation of scientific and technological products, precision medicine laboratories and the National Academy of Health Sciences as the main body. Develop two wings; we must adhere to the "two-wheel drive": that is, the transformation and incubation of hard-core scientific and technological innovation products, application scenarios and service formats of scientific and technological innovation products; we must realize the three-chain linkage of the innovation chain, industrial chain and capital chain. On the one hand, it is diligently exploring the technological track in the field of IVD, and on the other hand, it is focusing on the construction of innovative channels, changing its thinking, and seizing the development opportunities in the new era.
At the meeting site, the participating guests conducted in-depth discussions on financing plans and project cooperation plans, professionally shared the IVD market situation, offered suggestions, and jointly discussed new paths for Zhongsheng’s layout, bringing new ideas to the development of the company. At this point, the inauguration ceremony of the National Science Center General Health Research Institute’s Scientific and Technological Achievements Transformation Center and the Biomedical Instruments and Reagent Production Line came to a successful conclusion.
The implementation of this project marks that Zhongsheng has achieved a staged victory in further promoting cooperation between institutions and enterprises, scientific research cooperation, scientific and technological exchanges and achievement transformation. It is an important step in the strategic layout of Zhongsheng's industry.
In the future, Zhongsheng Beijing Enterprises will continue to adhere to independent innovation, actively seek external cooperation, build a scientific and technological innovation industry ecosystem, and adapt to new needs of market changes. Keep your heart as before, work hard and go far, and continue to write brilliant chapters on the journey to be a builder and leader of China's IVD industry. Fifty remarkable years, keep working hard and move forward!

Biosino Medical (Suzhou)

Telephone:400-867-1655

Mailbox:zskf@zhongshengbiotech.com

Address: Room 101, Building 3, No.8 Jinfeng Road, Suzhou High-tech Zone

Biosino Medical (Hefei)

Telephone:400-007-7620

Mailbox:zshf@zhongshengbiotech.com

Address: West Half Floor, Floor 2, Building 2, Phase II, Intelligent Science Park, 3959 Susong Road, Hefei Economic and Technological Development Zone, Anhui Province

QR Code

middle school students

Copyright ©Biosino (Suzhou) Medical Technology Co,.Ltd    SEO  www.300.cn

Business License

CONTACT US:

Look forward to your call anytime

400Tel:400-867-1655

Sales Hotline:0512-66182066